secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2021-11-01T23:59:59+00:00
Accession:  0001558370-21-013927
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio COO Jill Quigley to depart Dec 31, 2021; separation agreement signed
--------------------------------------------------------------------------------

- COO Jill Quigley voluntarily departs Dec 31, 2021 to pursue other interests; no disagreement over business.
- Separation agreement includes 12-month base salary lump sum, 12-month COBRA, 2021 target bonus, equity acceleration.
- Her COO responsibilities will be assumed by other members of the executive team.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000155837021013927/0001558370-21-013927-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000155837021013927/tmb-20211026x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-013927

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer